Rinatabart sesutecan (Rina-S) for patients with advanced endometrial cancer: First disclosure from dose expansion cohort B2 of the GTC1184-01 study.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Ira Seth Winer, Noelle Cloven, Debra L. Richardson, Lyndsay Willmott, Justin Call, Jessica Thomes Pepin, Gottfried E. Konecny, Andrea Jewell, Cara Amanda Mathews, Leigh Seamon, Joseph Buscema, Nurgul Kilavuz, Michael Gillespie, Ibrahima Soumaoro, Elizabeth Katherine Lee
Institutions: Wayne State University, The Barbara Ann Karmanos Cancer Institute, OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, HonorHealth, Minnesota Oncology, University of California, Los Angeles, UCLA Health, University of Kansas Medical Center, Brown University, Arizona Oncology, Genmab (United States), Dana-Farber Cancer Institute
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410814970